The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FDA 'No Objection' ruling on new product

21 Jul 2010 07:00

RNS Number : 6497P
PureCircle Limited
21 July 2010
 



PureCircle receives FDA GRAS "No Objection" for new SG95 stevia product

 

PureCircle (LSE: PURE), the world's leading producer of high purity stevia products, is pleased to announce that the US Food and Drug Administration (FDA) has issued a No Objection letter for the use of PureCircle's SG95 product as a Food and Beverage ingredient in the USA. This will enable PureCircle to offer a wider and more flexible array of stevia solutions, helping to further accelerate stevia adoption in the important USA market.

 

PureCircle's high purity SG95 product is a further example of the company's leadership in innovation. Along with seven previously approved steviol glycosides, SG95 includes two new steviol gylcosides, Rebaudioside D and Rebaudioside F, both of which are receiving GRAS No Objection for the first time. The new high purity sweetener delivers great taste and consistency as well as pricing well below sugar. The product is ideally suited for applications formulated with both sugar and SG95 to achieve a low cost solution to partial sugar and calorie reduction and provide further incentive to application development. Together with PureCircle's successful high purity Reb A 97, SG95 will provide customers with an expanded range of options to improve products across their portfolios. With GRAS affirmation, PureCircle is prepared for immediate commercialisation of SG95.

 

Magomet Malsagov, CEO and Managing Director of PureCircle, said: "The launch of SG95 is a very exciting development for PureCircle in the United States with considerable future potential in global markets. Expanded use of sweet glycosides from the stevia plant in a highly consistent blend provides both formulation and economic benefits to our customers. Our Reb A 97 continues to play a major role in our portfolio particularly as our investments yield continued efficiencies that will be shared with our customers. Now SG95 will provide an additional compelling product in many applications. We are proud to continue to be at the forefront of innovation to help mainstream a better sweet choice for consumers. "

 

For more information:

PureCircle Limited (www.purecircle.com)

Jason Hecker, Group Marketing Director

(847) 630-0374

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO 

+44 7974 005 163 

Westport Communications

+44 20 7065 2690

Alan Frame

alan@westportcomms.com

Jeanette Bishop

RFC Corporate Finance Ltd

+61 8 9480 2500 

Stephen Allen

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
REAPGURPMUPUGQU
Date   Source Headline
6th Feb 20187:00 amRNSNotice of Results
1st Feb 20187:00 amRNSTotal Voting Rights
2nd Jan 20187:00 amRNSBlock Listing Six Monthly Return
1st Dec 20179:50 amRNSResult of AGM
18th Oct 20177:00 amRNSNotice of AGM
29th Sep 20173:39 pmRNSDirector/PDMR Shareholding
29th Sep 20173:39 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:46 pmRNSDirector/PDMR Shareholding
19th Sep 20177:00 amRNSFinal Results
31st Aug 20177:00 amRNSInclusion in FTSE All-share index
15th Aug 20177:00 amRNSNotice of Results
1st Aug 20177:00 amRNSTotal Voting Rights
17th Jul 20178:37 amRNSDirector/PDMR Shareholding
13th Jul 20178:31 amRNSAppointment of Director - Correction
11th Jul 20177:00 amRNSAdditional Listing
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20177:00 amRNSBlock Listing Six Monthly Return
22nd Jun 20177:00 amRNSAppointment of Director
22nd Jun 20177:00 amRNSBoard Committee Changes
2nd Jun 20178:06 amRNSHolding(s) in Company
30th May 201711:05 amRNSDirector Declaration
17th May 20177:00 amRNSIP and patent protection developments
2nd May 20177:00 amRNSTrading Update
2nd May 20177:00 amRNSTotal Voting Rights
26th Apr 20179:45 amRNSCompany Secretary Name Change
25th Apr 20171:17 pmRNSDirector/PDMR Shareholding
15th Mar 20179:58 amRNSDirector/PDMR Shareholding
9th Mar 201711:19 amRNSDirector/PDMR Shareholding
7th Mar 20177:00 amRNSHalf Yearly Report
2nd Mar 201710:00 amRNSPureCircle Completes Stevia Plant Expansion
31st Jan 20177:00 amRNSTotal Voting Rights
30th Jan 20177:00 amRNSRemoval of Restriction on Imports into the U.S.
26th Jan 20174:40 pmRNSSecond Price Monitoring Extn
26th Jan 20174:35 pmRNSPrice Monitoring Extension
20th Jan 201711:34 amRNSDirector/PDMR Shareholding
10th Jan 20177:00 amRNSRelease of U.S. Shipments
5th Jan 20177:00 amRNSTrading Update
3rd Jan 20174:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20174:35 pmRNSPrice Monitoring Extension
30th Dec 20167:00 amRNSBlock listing Interim Review
1st Dec 20169:36 amRNSResult of AGM
14th Nov 20167:00 amRNSDirector/PDMR Shareholding
14th Nov 20167:00 amRNSDirector/PDMR Shareholding
2nd Nov 20168:31 amRNSNotice of AGM and Annual Report: Amendment
2nd Nov 20167:00 amRNSNotice of AGM and Annual Report
1st Nov 20167:00 amRNSAppointment of Chief Operating Officer
31st Oct 20167:00 amRNSTotal Voting Rights
11th Oct 20164:48 pmRNSDirector/PDMR Shareholding
30th Sep 20167:00 amRNSTotal Voting Rights
28th Sep 20164:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.